Gamma scintigraphic comparison of eyedrops containing pilocarpine in healthy volunteers
The aim of the present study was to compare, in healthy human volunteers (male and female), the corneal contact time of various formulations, each containing one viscosity enhancer from the following list: a phase-transition system (gellan gum, Gelrite), a heteropolysaccharide (xanthan gum) and curr...
Gespeichert in:
Veröffentlicht in: | Journal of ocular pharmacology and therapeutics 1996, Vol.12 (4), p.481-488 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 488 |
---|---|
container_issue | 4 |
container_start_page | 481 |
container_title | Journal of ocular pharmacology and therapeutics |
container_volume | 12 |
creator | MESEGUER, G BURT, P PLAZONNET, B ROZIER, A GURNY, R |
description | The aim of the present study was to compare, in healthy human volunteers (male and female), the corneal contact time of various formulations, each containing one viscosity enhancer from the following list: a phase-transition system (gellan gum, Gelrite), a heteropolysaccharide (xanthan gum) and currently used polymers hydroxyethylcellulose, hydroxypropylmethylcellulose, or poly(vinyl alcohol). These different solutions were compared to a reference solution containing no viscosity enhancers. The corneal contact time of the formulations was evaluated over more than 20 minutes by gamma scintigraphy using Technetium-99m (Tc-99m DTPA) as a radioactive label. An eyedrop containing pilocarpine salts (25 microliters) was instilled in one eye only. Each volunteer received 4 formulations, the interval between the instillations being one week. The protocol has been approved by the relevant institutional human experimentation committee. One minute after instillation, only 23% of the reference solution remained on the ocular surface, whereas the novel formulations maintained, respectively, 77% (xanthan gum) or 82% (Gelrite) of the tracer on the ocular surface. Twenty-one min after instillation, 12% (reference solution), 25% (xanthan gum solution), and 39% (gelrite solution) of the tracer remained on the ocular surface. The results confirm that an increase in viscosity of the formulation (xanthan) delays the clearance of the instilled solution by the tear flow. The effect of the gelation mechanism is superior, especially at the later time points. In this respect, xanthan gum and, particularly, Gelrite are suitable vehicles for ophthalmic drugs. |
doi_str_mv | 10.1089/jop.1996.12.481 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78594511</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78594511</sourcerecordid><originalsourceid>FETCH-LOGICAL-c321t-331070ded3f595951b3eaeb074ec50fcd80bdbc32b39d1beb206e4f48d33b0af3</originalsourceid><addsrcrecordid>eNo9kEFr3DAQRkVoSTfbnHMK-FB68-6MZdnysSxpEgjk0tKjkORxVostuZK3sP--CruEOcww8-Y7PMbuEDYIstsewrzBrms2WG1qiVdshUK0Zdvy6lOeQULZNpJ_YTcpHQCQQ4PX7Fp2AhtZr9ifRz1NukjW-cW9RT3vnS1smGYdXQq-CENBJ-pjmFNe-0U77_xbMbsxWB1n56lwvtiTHpf9qfgXxqNfiGL6yj4Pekx0e-lr9vvnw6_dU_ny-vi8-_FSWl7hUnKO0EJPPR9ElwsNJ00G2pqsgMH2EkxvMmt416MhU0FD9VDLnnMDeuBr9v2cO8fw90hpUZNLlsZRewrHpFopulogZnB7Bm0MKUUa1BzdpONJIah3lSqrVO8qFVYqq8wf95foo5mo_-Av7vL92-Wuk9XjELW3Ln1glahaEMD_A7dpfsg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78594511</pqid></control><display><type>article</type><title>Gamma scintigraphic comparison of eyedrops containing pilocarpine in healthy volunteers</title><source>Mary Ann Liebert Online Subscription</source><source>MEDLINE</source><creator>MESEGUER, G ; BURT, P ; PLAZONNET, B ; ROZIER, A ; GURNY, R</creator><creatorcontrib>MESEGUER, G ; BURT, P ; PLAZONNET, B ; ROZIER, A ; GURNY, R</creatorcontrib><description>The aim of the present study was to compare, in healthy human volunteers (male and female), the corneal contact time of various formulations, each containing one viscosity enhancer from the following list: a phase-transition system (gellan gum, Gelrite), a heteropolysaccharide (xanthan gum) and currently used polymers hydroxyethylcellulose, hydroxypropylmethylcellulose, or poly(vinyl alcohol). These different solutions were compared to a reference solution containing no viscosity enhancers. The corneal contact time of the formulations was evaluated over more than 20 minutes by gamma scintigraphy using Technetium-99m (Tc-99m DTPA) as a radioactive label. An eyedrop containing pilocarpine salts (25 microliters) was instilled in one eye only. Each volunteer received 4 formulations, the interval between the instillations being one week. The protocol has been approved by the relevant institutional human experimentation committee. One minute after instillation, only 23% of the reference solution remained on the ocular surface, whereas the novel formulations maintained, respectively, 77% (xanthan gum) or 82% (Gelrite) of the tracer on the ocular surface. Twenty-one min after instillation, 12% (reference solution), 25% (xanthan gum solution), and 39% (gelrite solution) of the tracer remained on the ocular surface. The results confirm that an increase in viscosity of the formulation (xanthan) delays the clearance of the instilled solution by the tear flow. The effect of the gelation mechanism is superior, especially at the later time points. In this respect, xanthan gum and, particularly, Gelrite are suitable vehicles for ophthalmic drugs.</description><identifier>ISSN: 1080-7683</identifier><identifier>EISSN: 1557-7732</identifier><identifier>DOI: 10.1089/jop.1996.12.481</identifier><identifier>PMID: 8951684</identifier><language>eng</language><publisher>Larchmont, NY: Liebert</publisher><subject>Biological and medical sciences ; Biological Availability ; Cornea - diagnostic imaging ; Cornea - metabolism ; Drug Carriers ; Eye ; Female ; Gels ; General pharmacology ; Humans ; Male ; Medical sciences ; Muscarinic Agonists - pharmacokinetics ; Ophthalmic Solutions - pharmacokinetics ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Pilocarpine - pharmacokinetics ; Polymers ; Polysaccharides, Bacterial ; Radionuclide Imaging ; Radiopharmaceuticals - pharmacokinetics ; Technetium Tc 99m Pentetate - pharmacokinetics ; Viscosity</subject><ispartof>Journal of ocular pharmacology and therapeutics, 1996, Vol.12 (4), p.481-488</ispartof><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c321t-331070ded3f595951b3eaeb074ec50fcd80bdbc32b39d1beb206e4f48d33b0af3</citedby><cites>FETCH-LOGICAL-c321t-331070ded3f595951b3eaeb074ec50fcd80bdbc32b39d1beb206e4f48d33b0af3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3042,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2527050$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8951684$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MESEGUER, G</creatorcontrib><creatorcontrib>BURT, P</creatorcontrib><creatorcontrib>PLAZONNET, B</creatorcontrib><creatorcontrib>ROZIER, A</creatorcontrib><creatorcontrib>GURNY, R</creatorcontrib><title>Gamma scintigraphic comparison of eyedrops containing pilocarpine in healthy volunteers</title><title>Journal of ocular pharmacology and therapeutics</title><addtitle>J Ocul Pharmacol Ther</addtitle><description>The aim of the present study was to compare, in healthy human volunteers (male and female), the corneal contact time of various formulations, each containing one viscosity enhancer from the following list: a phase-transition system (gellan gum, Gelrite), a heteropolysaccharide (xanthan gum) and currently used polymers hydroxyethylcellulose, hydroxypropylmethylcellulose, or poly(vinyl alcohol). These different solutions were compared to a reference solution containing no viscosity enhancers. The corneal contact time of the formulations was evaluated over more than 20 minutes by gamma scintigraphy using Technetium-99m (Tc-99m DTPA) as a radioactive label. An eyedrop containing pilocarpine salts (25 microliters) was instilled in one eye only. Each volunteer received 4 formulations, the interval between the instillations being one week. The protocol has been approved by the relevant institutional human experimentation committee. One minute after instillation, only 23% of the reference solution remained on the ocular surface, whereas the novel formulations maintained, respectively, 77% (xanthan gum) or 82% (Gelrite) of the tracer on the ocular surface. Twenty-one min after instillation, 12% (reference solution), 25% (xanthan gum solution), and 39% (gelrite solution) of the tracer remained on the ocular surface. The results confirm that an increase in viscosity of the formulation (xanthan) delays the clearance of the instilled solution by the tear flow. The effect of the gelation mechanism is superior, especially at the later time points. In this respect, xanthan gum and, particularly, Gelrite are suitable vehicles for ophthalmic drugs.</description><subject>Biological and medical sciences</subject><subject>Biological Availability</subject><subject>Cornea - diagnostic imaging</subject><subject>Cornea - metabolism</subject><subject>Drug Carriers</subject><subject>Eye</subject><subject>Female</subject><subject>Gels</subject><subject>General pharmacology</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Muscarinic Agonists - pharmacokinetics</subject><subject>Ophthalmic Solutions - pharmacokinetics</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Pilocarpine - pharmacokinetics</subject><subject>Polymers</subject><subject>Polysaccharides, Bacterial</subject><subject>Radionuclide Imaging</subject><subject>Radiopharmaceuticals - pharmacokinetics</subject><subject>Technetium Tc 99m Pentetate - pharmacokinetics</subject><subject>Viscosity</subject><issn>1080-7683</issn><issn>1557-7732</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kEFr3DAQRkVoSTfbnHMK-FB68-6MZdnysSxpEgjk0tKjkORxVostuZK3sP--CruEOcww8-Y7PMbuEDYIstsewrzBrms2WG1qiVdshUK0Zdvy6lOeQULZNpJ_YTcpHQCQQ4PX7Fp2AhtZr9ifRz1NukjW-cW9RT3vnS1smGYdXQq-CENBJ-pjmFNe-0U77_xbMbsxWB1n56lwvtiTHpf9qfgXxqNfiGL6yj4Pekx0e-lr9vvnw6_dU_ny-vi8-_FSWl7hUnKO0EJPPR9ElwsNJ00G2pqsgMH2EkxvMmt416MhU0FD9VDLnnMDeuBr9v2cO8fw90hpUZNLlsZRewrHpFopulogZnB7Bm0MKUUa1BzdpONJIah3lSqrVO8qFVYqq8wf95foo5mo_-Av7vL92-Wuk9XjELW3Ln1glahaEMD_A7dpfsg</recordid><startdate>1996</startdate><enddate>1996</enddate><creator>MESEGUER, G</creator><creator>BURT, P</creator><creator>PLAZONNET, B</creator><creator>ROZIER, A</creator><creator>GURNY, R</creator><general>Liebert</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1996</creationdate><title>Gamma scintigraphic comparison of eyedrops containing pilocarpine in healthy volunteers</title><author>MESEGUER, G ; BURT, P ; PLAZONNET, B ; ROZIER, A ; GURNY, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c321t-331070ded3f595951b3eaeb074ec50fcd80bdbc32b39d1beb206e4f48d33b0af3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Biological and medical sciences</topic><topic>Biological Availability</topic><topic>Cornea - diagnostic imaging</topic><topic>Cornea - metabolism</topic><topic>Drug Carriers</topic><topic>Eye</topic><topic>Female</topic><topic>Gels</topic><topic>General pharmacology</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Muscarinic Agonists - pharmacokinetics</topic><topic>Ophthalmic Solutions - pharmacokinetics</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Pilocarpine - pharmacokinetics</topic><topic>Polymers</topic><topic>Polysaccharides, Bacterial</topic><topic>Radionuclide Imaging</topic><topic>Radiopharmaceuticals - pharmacokinetics</topic><topic>Technetium Tc 99m Pentetate - pharmacokinetics</topic><topic>Viscosity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MESEGUER, G</creatorcontrib><creatorcontrib>BURT, P</creatorcontrib><creatorcontrib>PLAZONNET, B</creatorcontrib><creatorcontrib>ROZIER, A</creatorcontrib><creatorcontrib>GURNY, R</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of ocular pharmacology and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MESEGUER, G</au><au>BURT, P</au><au>PLAZONNET, B</au><au>ROZIER, A</au><au>GURNY, R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gamma scintigraphic comparison of eyedrops containing pilocarpine in healthy volunteers</atitle><jtitle>Journal of ocular pharmacology and therapeutics</jtitle><addtitle>J Ocul Pharmacol Ther</addtitle><date>1996</date><risdate>1996</risdate><volume>12</volume><issue>4</issue><spage>481</spage><epage>488</epage><pages>481-488</pages><issn>1080-7683</issn><eissn>1557-7732</eissn><abstract>The aim of the present study was to compare, in healthy human volunteers (male and female), the corneal contact time of various formulations, each containing one viscosity enhancer from the following list: a phase-transition system (gellan gum, Gelrite), a heteropolysaccharide (xanthan gum) and currently used polymers hydroxyethylcellulose, hydroxypropylmethylcellulose, or poly(vinyl alcohol). These different solutions were compared to a reference solution containing no viscosity enhancers. The corneal contact time of the formulations was evaluated over more than 20 minutes by gamma scintigraphy using Technetium-99m (Tc-99m DTPA) as a radioactive label. An eyedrop containing pilocarpine salts (25 microliters) was instilled in one eye only. Each volunteer received 4 formulations, the interval between the instillations being one week. The protocol has been approved by the relevant institutional human experimentation committee. One minute after instillation, only 23% of the reference solution remained on the ocular surface, whereas the novel formulations maintained, respectively, 77% (xanthan gum) or 82% (Gelrite) of the tracer on the ocular surface. Twenty-one min after instillation, 12% (reference solution), 25% (xanthan gum solution), and 39% (gelrite solution) of the tracer remained on the ocular surface. The results confirm that an increase in viscosity of the formulation (xanthan) delays the clearance of the instilled solution by the tear flow. The effect of the gelation mechanism is superior, especially at the later time points. In this respect, xanthan gum and, particularly, Gelrite are suitable vehicles for ophthalmic drugs.</abstract><cop>Larchmont, NY</cop><pub>Liebert</pub><pmid>8951684</pmid><doi>10.1089/jop.1996.12.481</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1080-7683 |
ispartof | Journal of ocular pharmacology and therapeutics, 1996, Vol.12 (4), p.481-488 |
issn | 1080-7683 1557-7732 |
language | eng |
recordid | cdi_proquest_miscellaneous_78594511 |
source | Mary Ann Liebert Online Subscription; MEDLINE |
subjects | Biological and medical sciences Biological Availability Cornea - diagnostic imaging Cornea - metabolism Drug Carriers Eye Female Gels General pharmacology Humans Male Medical sciences Muscarinic Agonists - pharmacokinetics Ophthalmic Solutions - pharmacokinetics Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments Pilocarpine - pharmacokinetics Polymers Polysaccharides, Bacterial Radionuclide Imaging Radiopharmaceuticals - pharmacokinetics Technetium Tc 99m Pentetate - pharmacokinetics Viscosity |
title | Gamma scintigraphic comparison of eyedrops containing pilocarpine in healthy volunteers |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T09%3A38%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gamma%20scintigraphic%20comparison%20of%20eyedrops%20containing%20pilocarpine%20in%20healthy%20volunteers&rft.jtitle=Journal%20of%20ocular%20pharmacology%20and%20therapeutics&rft.au=MESEGUER,%20G&rft.date=1996&rft.volume=12&rft.issue=4&rft.spage=481&rft.epage=488&rft.pages=481-488&rft.issn=1080-7683&rft.eissn=1557-7732&rft_id=info:doi/10.1089/jop.1996.12.481&rft_dat=%3Cproquest_cross%3E78594511%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78594511&rft_id=info:pmid/8951684&rfr_iscdi=true |